Imagion Biosystems (ASX:IBX) Other Cash Receipts from Operating Activities : A$0.36 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Imagion Biosystems Other Cash Receipts from Operating Activities?

Imagion Biosystems's Other Cash Receipts from Operating Activities for the six months ended in Dec. 2024 was A$-0.13 Mil.

Imagion Biosystems's Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.36 Mil.

Imagion Biosystems Other Cash Receipts from Operating Activities Historical Data

The historical data trend for Imagion Biosystems's Other Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imagion Biosystems Other Cash Receipts from Operating Activities Chart

Imagion Biosystems Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Cash Receipts from Operating Activities

Get a 7-Day Free Trial

2.20

2.61

2.52

Imagion Biosystems Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Cash Receipts from Operating Activities	Get a 7-Day Free Trial											2.52	-	3.53	0.49	-0.13

Imagion Biosystems Other Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Other Cash Receipts from Operating Activities represents cash flow received from other operating activities in the direct cash flow method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Other Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.36 Mil.

Imagion Biosystems Other Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of Imagion Biosystems's Other Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Imagion Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Imagion Biosystems Ltd (ASX:IBX) » Definitions » Other Cash Receipts from Operating Activities

Comparable Companies

Traded in Other Exchanges

IBXXF:USA

Address

96-100 Albert Road, Level 4, South Melbourne, VIC, AUS, 3205

Website

https://www.imagionbiosystems.com

Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.

Imagion Biosystems Headlines

No Headlines